Radiopharmacy in Africa: current status and future directions

F P Ekoume; S M Rubow; A Elrefaei; N Bentaleb; A Korde; B Summers; S Bouyoucef; V Radchenko; C Vraka; V Pichler

doi:10.1016/j.nucmedbio.2022.08.002

Radiopharmacy in Africa: current status and future directions

F P Ekoume, S M Rubow, A Elrefaei, N Bentaleb, A Korde, B Summers, S Bouyoucef, V Radchenko, C Vraka, V Pichler

Department of Pharmaceutical Sciences

Publications: Contribution to journal › Article › Peer Reviewed

Abstract

This report is a summary of the first SRS-Africa meeting that was held virtually on the 15th of October 2021, to gain information on the status of radiopharmaceutical sciences in Africa. Registration data included information on participants' qualifications and field of work. An independent survey performed in Africa prior to the meeting elicited details of available staff in different countries, facilities and equipment, radionuclides and radiopharmaceuticals used, research undertaken and difficulties experienced. We present here a brief overview of this meeting's topics of discussion, including ongoing research, gaps and challenges, and local opportunities.

Original language	English
Pages (from-to)	29-33
Number of pages	5
Journal	Nuclear Medicine and Biology
Volume	114-115
DOIs	https://doi.org/10.1016/j.nucmedbio.2022.08.002
Publication status	Published - 1 Nov 2022

Austrian Fields of Science 2012

104020 Radiochemistry
303026 Public health

Keywords

Africa
Challenges
Opportunities
Radiochemistry
Radiopharmacy
Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.nucmedbio.2022.08.002

Cite this

@article{2a94867d1f4b4e809f3574c95d8ecfda,

title = "Radiopharmacy in Africa: current status and future directions",

abstract = "This report is a summary of the first SRS-Africa meeting that was held virtually on the 15th of October 2021, to gain information on the status of radiopharmaceutical sciences in Africa. Registration data included information on participants' qualifications and field of work. An independent survey performed in Africa prior to the meeting elicited details of available staff in different countries, facilities and equipment, radionuclides and radiopharmaceuticals used, research undertaken and difficulties experienced. We present here a brief overview of this meeting's topics of discussion, including ongoing research, gaps and challenges, and local opportunities.",

keywords = "Africa, Challenges, Opportunities, Radiochemistry, Radiopharmacy, Research",

author = "Ekoume, {F P} and Rubow, {S M} and A Elrefaei and N Bentaleb and A Korde and B Summers and S Bouyoucef and V Radchenko and C Vraka and V Pichler",

note = "Funding Information: The support of the SRS board and the SRSTT is gratefully acknowledged. We want to thank Charles Metzger and Bailey Threadgill-Wolberg for technical and organizational support throughout the eSRS Africa meeting. The authors also thank Jason Lewis for helping with editing the paper, and Antony Gee for useful advice. Data was provided by the following responders to the questionnaire: Kleynhans J (South Africa), Itotia E (Kenya), Lundie M (South Africa), Mounibe D (Senegal), Gansonre V (Burkina Faso), Mangatha A (Mauritus), Sakala R (Zambia), Kibwika M (Uganda), Kibatu G (Ethiopia), Senghor S (Senegal), Minda DA (Ethiopia), Mansur S (Nigeria), Orunmuyi A (Nigeria), Seeneevassen A (Mauritus), Mwazembeni J (South Africa), Mosima L (South Africa), Mbalenhle S (South Africa), Du Plessis S (South Africa), Moloto T (South Africa). Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

month = nov,

day = "1",

doi = "10.1016/j.nucmedbio.2022.08.002",

language = "English",

volume = "114-115",

pages = "29--33",

journal = "Nuclear Medicine and Biology",

issn = "0969-8051",

publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",

}

TY - JOUR

T1 - Radiopharmacy in Africa

T2 - current status and future directions

AU - Ekoume, F P

AU - Rubow, S M

AU - Elrefaei, A

AU - Bentaleb, N

AU - Korde, A

AU - Summers, B

AU - Bouyoucef, S

AU - Radchenko, V

AU - Vraka, C

AU - Pichler, V

N1 - Funding Information: The support of the SRS board and the SRSTT is gratefully acknowledged. We want to thank Charles Metzger and Bailey Threadgill-Wolberg for technical and organizational support throughout the eSRS Africa meeting. The authors also thank Jason Lewis for helping with editing the paper, and Antony Gee for useful advice. Data was provided by the following responders to the questionnaire: Kleynhans J (South Africa), Itotia E (Kenya), Lundie M (South Africa), Mounibe D (Senegal), Gansonre V (Burkina Faso), Mangatha A (Mauritus), Sakala R (Zambia), Kibwika M (Uganda), Kibatu G (Ethiopia), Senghor S (Senegal), Minda DA (Ethiopia), Mansur S (Nigeria), Orunmuyi A (Nigeria), Seeneevassen A (Mauritus), Mwazembeni J (South Africa), Mosima L (South Africa), Mbalenhle S (South Africa), Du Plessis S (South Africa), Moloto T (South Africa). Publisher Copyright: © 2022 Elsevier Inc.

PY - 2022/11/1

Y1 - 2022/11/1

N2 - This report is a summary of the first SRS-Africa meeting that was held virtually on the 15th of October 2021, to gain information on the status of radiopharmaceutical sciences in Africa. Registration data included information on participants' qualifications and field of work. An independent survey performed in Africa prior to the meeting elicited details of available staff in different countries, facilities and equipment, radionuclides and radiopharmaceuticals used, research undertaken and difficulties experienced. We present here a brief overview of this meeting's topics of discussion, including ongoing research, gaps and challenges, and local opportunities.

AB - This report is a summary of the first SRS-Africa meeting that was held virtually on the 15th of October 2021, to gain information on the status of radiopharmaceutical sciences in Africa. Registration data included information on participants' qualifications and field of work. An independent survey performed in Africa prior to the meeting elicited details of available staff in different countries, facilities and equipment, radionuclides and radiopharmaceuticals used, research undertaken and difficulties experienced. We present here a brief overview of this meeting's topics of discussion, including ongoing research, gaps and challenges, and local opportunities.

KW - Africa

KW - Challenges

KW - Opportunities

KW - Radiochemistry

KW - Radiopharmacy

KW - Research

UR - http://www.scopus.com/inward/record.url?scp=85137272760&partnerID=8YFLogxK

U2 - 10.1016/j.nucmedbio.2022.08.002

DO - 10.1016/j.nucmedbio.2022.08.002

M3 - Article

C2 - 36088874

AN - SCOPUS:85137272760

SN - 0969-8051

VL - 114-115

SP - 29

EP - 33

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

ER -

Radiopharmacy in Africa: current status and future directions

Abstract

Austrian Fields of Science 2012

Keywords

UN SDGs

Access to Document

Other files and links

Cite this